HIGHLIGHTS
- who: Andrea M. Hanson from the Published in cooperation with the Biodesign Institute at Arizona State University, with the support of NASA have published the paper: Inhibiting myostatin signaling partially mitigates structural and functional adaptations to hindlimb suspension in mice, in the Journal: (JOURNAL)
- what: The authors used a highly specific anti-myostatin peptibody inhibitor of myostatin to evaluate the role of myostatin signaling in hindlimb suspension muscle pathology.
- how: Group-wise comparisons showed that in vehicle-treated mice (HS-P) suspension significantly reduced hindlimb force by -19.8% (p and amplt 0 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.